what is going on with compounded tirzepatide versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter Thursday. Following laboratory testing, the drugmaker said Mounjaro and Zepbound Are No
Description
The side effect profiles of these medications also connect to the expiration discussion
Some contained zero active ingredient
[Accessed 05/08/2025] 3
Tirzepatide produces 16-22.5% body weight loss over 72 weeks
All cases were classified as mild with no necrotising pancreatitis observed and approximately 80% had confounding risk factors including gallstones or alcohol use
Or that injecting in the thigh leads to more injection site reactions than the abdomen
